| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT06719310 Phase Ib/IIa Clinical Study of ACC017 Tablets |
Trial completed |
| 2026-08-15 | NCT06719310 Phase Ib/IIa Clinical Study of ACC017 Tablets |
date change Primary completion moved earlier: 2025-08 -> 2025-04-28 |
| 2026-08-15 | NCT06719310 Phase Ib/IIa Clinical Study of ACC017 Tablets |
date change Completion moved earlier: 2025-11 -> 2025-04-28 |
| 2026-08-06 | NCT07729839 Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection |
Enrollment increased: 26 -> 34 participants |
| 2026-08-06 | NCT07729839 Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection |
Trial arms changed: 5 -> 6 |
| 2026-08-06 | NCT07729839 Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection |
date change Primary completion pushed: 2026-08-30 -> 2026-12-30 |
| 2026-08-06 | NCT07729839 Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection |
date change Completion pushed: 2026-08-30 -> 2027-03-18 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-10 | NCT07753902 Bioequivalence Study of ADC118 Tablets in Healthy Chinese Volunteers Under Fasting… | Phase 1 | Completed |
| 2026-07-28 | NCT07729839 Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT07711223 | Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in… | Infection, Human Immunodeficiency Virus | Recruiting |
| NCT07711210 | Efficacy and Safety of the ACC017-Based Antiretroviral Regimen in Treatment-Experienced… | Infection, Human Immunodeficiency Virus | Active, Not Recruiting |
| Phase 1 | |||
| NCT07729839 | Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection | Healthy Adult Participants | Recruiting |